Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,493.90
(
-1.49%
)
US TECH 100
23,035.99
(
-2.03%
)
Dow Jones
46,010.64
(
-0.90%
)
Brent Oil
102.58
(
3.85%
)
Bitcoin
68,136.80
(
-4.44%
)
News Focus
News Focus
Post# of 257293
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rogerm

Send PM Follow Ignore
Followers 2
Posts 112
Boards Moderated 0
Alias Born 08/04/2005

rogerm

Re: DewDiligence post# 201081

Monday, 05/02/2016 7:34:33 PM

Monday, May 02, 2016 7:34:33 PM

Post# of 257293
If Inter Partes Review is overturned by the supreme court do you think it will have much of an effect on settling legal drug patent issues? Should a MNTA or bio shareholder care about the decision either way? I'm not a lawyer but was thinking if IPR can reduce lawsuits then its generally good for bios. But I don't know so interested in other opinions. Sounds like the supreme court decides next month.
http://www.ipwatchdog.com/2016/04/24/cuozzo-supreme-court-value-inter-partes-reviews/id=68552/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today